108 related articles for article (PubMed ID: 17715172)
1. Cytokines in arthritis--the 'big numbers' move centre stage.
Gaston JS
Rheumatology (Oxford); 2008 Jan; 47(1):8-12. PubMed ID: 17715172
[TBL] [Abstract][Full Text] [Related]
2. Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides.
Jandus C; Bioley G; Rivals JP; Dudler J; Speiser D; Romero P
Arthritis Rheum; 2008 Aug; 58(8):2307-17. PubMed ID: 18668556
[TBL] [Abstract][Full Text] [Related]
3. IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?
Lubberts E
Cytokine; 2008 Feb; 41(2):84-91. PubMed ID: 18039580
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells in rheumatoid arthritis: Which subset should be used as a tool to induce tolerance?
Lebre MC; Tak PP
Hum Immunol; 2009 May; 70(5):321-4. PubMed ID: 19236901
[TBL] [Abstract][Full Text] [Related]
5. Targeting the development and effector functions of TH17 cells.
Ghilardi N; Ouyang W
Semin Immunol; 2007 Dec; 19(6):383-93. PubMed ID: 18083530
[TBL] [Abstract][Full Text] [Related]
6. The link between IL-23 and Th17 cell-mediated immune pathologies.
McGeachy MJ; Cua DJ
Semin Immunol; 2007 Dec; 19(6):372-6. PubMed ID: 18319054
[TBL] [Abstract][Full Text] [Related]
7. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.
Brand S
Gut; 2009 Aug; 58(8):1152-67. PubMed ID: 19592695
[TBL] [Abstract][Full Text] [Related]
8. Immune regulation of bone loss by Th17 cells.
Adamopoulos IE; Bowman EP
Arthritis Res Ther; 2008; 10(5):225. PubMed ID: 18983698
[TBL] [Abstract][Full Text] [Related]
9. CD4 T-cell differentiation and inflammatory bowel disease.
Zenewicz LA; Antov A; Flavell RA
Trends Mol Med; 2009 May; 15(5):199-207. PubMed ID: 19362058
[TBL] [Abstract][Full Text] [Related]
10. Immunopathogenesis and role of T cells in psoriasis.
Ghoreschi K; Weigert C; Röcken M
Clin Dermatol; 2007; 25(6):574-80. PubMed ID: 18021895
[TBL] [Abstract][Full Text] [Related]
11. APC-derived cytokines and T cell polarization in autoimmune inflammation.
Gutcher I; Becher B
J Clin Invest; 2007 May; 117(5):1119-27. PubMed ID: 17476341
[TBL] [Abstract][Full Text] [Related]
12. The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation.
Annunziato F; Cosmi L; Liotta F; Maggi E; Romagnani S
Int Immunol; 2008 Nov; 20(11):1361-8. PubMed ID: 18820263
[TBL] [Abstract][Full Text] [Related]
13. Plasticity of CD4+ T cell lineage differentiation.
Zhou L; Chong MM; Littman DR
Immunity; 2009 May; 30(5):646-55. PubMed ID: 19464987
[TBL] [Abstract][Full Text] [Related]
14. Immunoregulatory properties of vasoactive intestinal peptide in human T cell subsets: implications for rheumatoid arthritis.
Gutiérrez-Cañas I; Juarranz Y; Santiago B; Martínez C; Gomariz RP; Pablos JL; Leceta J
Brain Behav Immun; 2008 Mar; 22(3):312-7. PubMed ID: 17951026
[TBL] [Abstract][Full Text] [Related]
15. An insight into molecular mechanisms of human T helper cell differentiation.
Rautajoki KJ; Kylaniemi MK; Raghav SK; Rao K; Lahesmaa R
Ann Med; 2008; 40(5):322-35. PubMed ID: 18484344
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17 in inflammatory skin disorders.
van Beelen AJ; Teunissen MB; Kapsenberg ML; de Jong EC
Curr Opin Allergy Clin Immunol; 2007 Oct; 7(5):374-81. PubMed ID: 17873575
[TBL] [Abstract][Full Text] [Related]
17. Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patients.
Takahashi N; Matsumoto K; Saito H; Nanki T; Miyasaka N; Kobata T; Azuma M; Lee SK; Mizutani S; Morio T
J Immunol; 2009 May; 182(9):5515-27. PubMed ID: 19380800
[TBL] [Abstract][Full Text] [Related]
18. GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis.
van Hamburg JP; Mus AM; de Bruijn MJ; de Vogel L; Boon L; Cornelissen F; Asmawidjaja P; Hendriks RW; Lubberts E
Arthritis Rheum; 2009 Mar; 60(3):750-9. PubMed ID: 19248112
[TBL] [Abstract][Full Text] [Related]
19. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
[TBL] [Abstract][Full Text] [Related]
20. Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase.
Iwanami K; Matsumoto I; Tanaka-Watanabe Y; Inoue A; Mihara M; Ohsugi Y; Mamura M; Goto D; Ito S; Tsutsumi A; Kishimoto T; Sumida T
Arthritis Rheum; 2008 Mar; 58(3):754-63. PubMed ID: 18311788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
